By using cutting-edge technologies, we are radically transforming the way we deliver healthcare, patient monitoring and clinical trial studies.
About us
Our values
At KLAVA Innovation, our goal is to provide innovative digital solutions, enabling remote patient monitoring and thus contributing to the development of new treatments.
Our values
At KLAVA Innovation, our goal is to provide innovative digital solutions, enabling remote patient monitoring and thus contributing to the development of new treatments.
Meet our team
Didier has always been passionate about pure mathematics. A public school teacher in secondary school, he quickly preferred to turn to entrepreneurship by creating a tutoring organisation at a very young age, and then became the co-founder of a nationwide organisation specialising in home tutoring.
Subsequently, he created various companies based on new technologies and cyber security in companies. At the same time, as a law enthusiast, he followed a specific training at the Ecole Nationale de la Magistrature.
Currently involved in an innovative project, Didier is back in his favourite field and is very interested in complex mathematical algorithms and the link between artificial intelligence and new technologies.
Justine is our marketing manager. She is in charge of the company's initiatives in the areas of digital marketing, advertising, communications, corporate image development, market research and international growth.
Her goal is to introduce KLAVA's innovative solutions to the public and to new buyers around the world.
Alexia has a general engineering background from the Mines d'Albi and an academic semester at Polytechnique Milan where she specialised in nanomedicine and biotechnology.
After starting her career as a health innovation consultant in the creation of national and European funding, she held the position of Innovation Manager at the Nice University Hospital in the Neurology Department of the Peripheral Nervous System and Muscles.
She then built up a solid experience in the implementation of innovative projects, particularly in the discovery of biomarkers and new technologies in artificial intelligence.
Maud is in charge of developing therapies based on emotions and self-compassion aiming at a new way of learning, to replace the inappropriate behavior by a more adapted emotional behavior in period of withdrawal and abstinence to the substance.
Head of a hospital unit, he is the author of numerous works in the field of psychiatry and neuroscience.
Doctor Ivan GASMAN is also a lecturer at the Faculty of Medicine and at the Collège de France and is involved in clinical and epidemiological research.
Our partners
